reports
- GlobalData Healthcare Department
Global Blood Therapeutics Inc (GBT) - Financial Analysis Review
Global Blood Therapeutics Inc (GBT) - Financial Analysis Review Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. It's lead drug candidate GBT440 is an oral, small molecule drug for the treatment of sickle cell disease (SCD) is in Phase II clinical trial statge. GBT440 is a hemoglobin modifier which targets the mechanism of red blood cell...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.